Morningstar Direct Alternatives for Indian Equities and Funds
What Morningstar Direct is, where it is strong, and the India-first alternative for investors who need deep Indian equity and mutual-fund research.
Morningstar Direct is a global, institutional investment-analysis platform used by asset managers, wealth managers, and other financial institutions to research funds and securities, build and analyse portfolios, and produce reports at scale. If your work is centred on Indian listed companies and Indian mutual funds, the practical question is not whether Direct is capable, because it clearly is, but whether its India depth matches what a focused Indian research desk needs, and an India-first alternative like Altys Labs is worth weighing against the same tests.
This piece explains what Morningstar Direct actually does today, where it is genuinely strong, where the gap tends to open for an India-focused fundamental investor, and how Altys approaches that gap. It is not a takedown. Direct is a serious tool, and for global, funds-heavy mandates it is a natural fit.
What Morningstar Direct is and who it serves
Morningstar Direct is built on Morningstar’s large global database, which the company describes as covering more than 800,000 investments worldwide. It is aimed at professional investment teams: asset management firms, wealth managers, and institutions that need to search and screen investments, run manager research and due diligence, analyse portfolios, and generate compliant, presentation-ready reports.
The platform’s core capabilities cluster into a few areas. There is investment research and screening across asset classes, using custom screens, datasets, and Morningstar’s own ratings. There is portfolio work, including building portfolios, stress testing, and attribution analysis. There is reporting through tools such as Presentation Studio and performance reporting, with custom-branded output. Direct also offers data import and export and API access for Excel, Python, and similar workflows, plus an AI assistant built on Morningstar’s research and data.
Morningstar as a company does have an India presence, including equity research and ratings surfaced through Morningstar India. Direct itself, though, is a global product whose centre of gravity is worldwide funds and multi-asset data, not the granular filings-level view of a single national market.
Where Morningstar Direct is genuinely strong
It is worth being clear about what Direct does well, because those strengths are real and they are the reason so many institutions rely on it.
- Fund and multi-asset coverage. Morningstar built its reputation on fund data and ratings, and Direct reflects that. For manager selection, fund due diligence, and multi-asset analysis, the breadth is substantial.
- Global reach. If your mandate spans markets and asset classes, one platform covering a very large global universe is valuable, and Direct is designed for exactly that scale.
- Analytics and attribution. Portfolio construction, stress testing, and performance attribution are first-class parts of the product, not afterthoughts.
- Reporting. Polished, branded, repeatable reporting is a genuine time-saver for teams that produce client-facing or compliance output regularly.
- Institutional trust. Morningstar’s ratings and research carry recognition, which matters when work has to be defended to clients or committees.
For a global allocator or a fund-of-funds team, that combination is hard to beat, and an India-only tool would not replace it.
Where the gap opens for India-focused work
The gap is not about quality. It is about focus. A platform built to cover the whole world tends to run wide rather than deep on any single market, and Indian equity research rewards depth in specific places.
Serious work on an Indian company usually lives in the primary documents: annual and quarterly filings, earnings-call (concall) transcripts, management guidance, and shareholding patterns. It also depends on getting the boring things right, such as annual figures that reconcile to the four quarters, banks with correct per-share data, and one-off items that do not quietly distort a trend. A global tool can carry Indian data, but the granular filings-level and concall-level view, tuned to how Indian companies actually report, is a different kind of coverage from broad global fund data.
Two more tests matter especially for Indian research, and they are easy to overlook:
- Point-in-time correctness. Filings get revised and results get restated. If a platform overwrites history with today’s view, any backtest or historical comparison is quietly contaminated. Reconstructing what was actually known on a past date is what makes historical work honest. We wrote about this in why point-in-time data matters.
- Source linkage. For professional work, a number you cannot trace back to the exact filing, line, and date is a number you cannot easily defend.
None of this is a knock on Direct. It is simply that a global, funds-first platform and an India-first, filings-deep tool are solving different problems.
How Altys approaches Indian equities and funds
Altys Labs is an equity research and fundamental analysis platform built specifically for Indian stocks (NSE and BSE) and Indian mutual funds. It is aimed at professional users such as PMS firms, AIFs, family offices, and MFDs, and it is currently invite-only, in private preview.
The idea is to bring India’s market data into one place: company filings, concall transcripts, management guidance, shareholding patterns, more than 80 global and domestic macro series, FII and DII flows, factor scores, and mutual-fund data. On top of that data sit tools to screen, build financial models, forecast, and backtest a strategy. If you want the wider workflow view, see the institutional equity research workflow and how to read a concall like an analyst.
Three choices define how Altys approaches the India gap described above:
- India-first and India-deep. It is built around Indian equities and funds rather than being a global tool with light India coverage.
- Point-in-time data. It keeps data as it stood on each past date, so research and backtests reflect what was actually knowable then rather than restated history.
- Source-linked numbers. Every figure links back to its source document, line, and date, and figures are calculated from the company’s own filings. Forecasts come from explicit statistical methods rather than a language model guessing a growth rate.
To be clear about what Altys is not: it is not a broker, not a tip service, and not a SEBI-registered research analyst or adviser. It does not tell you what to buy or sell. It is software for doing your own research. Understanding how a figure is built matters here, which is why we cover topics like revenue mapping in plain terms.
Which fits whom
Neither tool is a strict upgrade on the other. They serve different centres of gravity.
| Morningstar Direct | Altys Labs | |
|---|---|---|
| Focus | Global funds, securities, multi-asset analysis | Indian equities (NSE/BSE) and Indian mutual funds |
| Best for | Global asset and wealth managers, fund due diligence, reporting at scale | Professional India desks: PMS, AIF, family offices, MFDs |
| India depth | Part of a broad global dataset | India-first, filings and concall level |
| Historical view | Global institutional data | Point-in-time, kept as it stood on each date |
| Traceability | Ratings and research from Morningstar | Every figure linked to source document, line, and date |
| Access | Enterprise, license-based, quote pricing | Invite-only, private preview |
A simple way to decide: if your work spans global markets and leans heavily on fund selection, multi-asset analytics, and polished reporting, Morningstar Direct is built for that and its breadth is a real advantage. If your work lives inside Indian companies and Indian funds, and you care about point-in-time history, concall and filings depth, and numbers you can trace to source, an India-first tool is worth testing against your own names.
The honest test is the same for any platform, including this one. Pick a handful of Indian companies you know cold, across a bank, a manufacturer, and a consumer name, check the numbers against the actual filings, try to trace one figure back to its source, and see whether the historical view is point-in-time honest. Whichever tool passes that test on the questions you actually work on is the right one for you. If you want a wider survey of the landscape, see our roundup of the best equity research tools in India, and a related view in alternatives to Morningstar for Indian equity research.
This article is about research tools, not securities. It is educational and does not contain investment advice or stock recommendations. Altys Labs is not a registered Research Analyst or Investment Adviser.
Frequently asked questions
Is Morningstar Direct available in India?
Morningstar Direct is a global institutional platform sold to asset and wealth managers worldwide, and Morningstar has an India presence through Morningstar India. Direct itself is built around global funds and securities data, so an India-focused investor should test how deep its Indian equity and filings coverage runs for the specific companies they follow.
What is Morningstar Direct best known for?
Broad global investment data, manager research and due diligence, ratings, portfolio analytics, and polished reporting. It is especially strong on funds and multi-asset analysis across a large worldwide database.
What is a good Morningstar Direct alternative for Indian stocks and funds?
For someone focused on Indian listed companies and Indian mutual funds, an India-first research tool that carries filings, concall transcripts, shareholding data, and fund data, with point-in-time history and source-linked numbers, is worth evaluating. Altys Labs is one such option, currently in private preview for professional users.
How much does Morningstar Direct cost?
Morningstar does not publish a fixed public price for Direct. It is an enterprise, license-based product, and pricing is arranged by quote based on users and modules, so you would confirm current terms with Morningstar directly.